Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) reports a Q3 loss of $0.30, 4 cents better than ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE